Yan Zhang, Si-Qi M A, Fei-Fei Yang, Jian-Yong S I, Qing W U, Yong-Hong Liao
School of Chinese Materia Medica, Beijing University of Chinese Medicine Beijing 100102, China Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100193, China.
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing 100193, China.
Zhongguo Zhong Yao Za Zhi. 2020 Nov;45(22):5421-5428. doi: 10.19540/j.cnki.cjcmm.20200623.205.
Pyrrolizidine alkaloids(PAs) are a group of naturally occurring alkaloids with a pyrrolizidine skeleton which can be found in about 3% of the world's flowering plants. It is notorious that PAs are cause the hepatoxic and genotoxic-carcinogenic effects by taking PA-containing herbs, food and dietary supplements. In order to control the poisoning caused by PAs, European Medicines Agency has set a limit of intake of PAs from herbal medicinal products at 0.007 μg of 1,2-unsaturated PAs/kg body weight. Nonetheless, a systematic overview of the amount of PAs in the herb has not been provided. Therefore, this paper is to systematically review the current status of PAs content analysis of herbal medicines and foods reported in the literature, and to provide theoretical and experimental support for the safety risk assessment and control of PAs in Chinese herbal medicines.
吡咯里西啶生物碱(PAs)是一类具有吡咯里西啶骨架的天然生物碱,约占世界上3%的开花植物。众所周知,摄入含PA的草药、食物和膳食补充剂会导致PAs产生肝毒性和基因毒性致癌作用。为了控制PAs引起的中毒,欧洲药品管理局规定草药产品中PAs的摄入量限制为每千克体重0.007μg的1,2-不饱和PAs。尽管如此,尚未提供草药中PAs含量的系统概述。因此,本文旨在系统综述文献报道的草药和食物中PAs含量分析的现状,为中药中PAs的安全风险评估和控制提供理论和实验支持。